Navigation Links
Insmed to Present at 31st Annual J.P. Morgan Healthcare Conference
Date:12/13/2012

hase 3 registrational study of ARIKACE (CLEAR-108) in Europe and Canada has completed enrollment, and the Company expects top-line clinical results in mid-2013.  Insmed's U.S. phase 2 clinical trial in NTM (TARGET-NTM) is well under way with clinical results expected in late 2013.  The Company is currently preparing for regulatory filings and for commercialization, if and when regulatory approvals are obtained. For more information, please visit http://www.insmed.com.

Forward-Looking Statements

This release contains forward-looking statements which are made pursuant to provisions of Section 21E of the Securities Exchange Act of 1934. Words, and variations of words, such as "intend", "expect", "will", "anticipate", "believe", "continue", "propose" and similar expressions are intended to identify forward-looking statements. Investors are cautioned that such statements in this release, including statements relating to the status, results and timing of results of pre-clinical studies and clinical trials and pre-clinical and clinical data and the anticipated benefits of Insmed's products, constitute forward-looking statements which involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, without limitation, failure or delay of U.S. Food and Drug Administration and other regulatory reviews and approvals, competitive developments affecting our product development, delays in product development or clinical trials, patent disputes involving currently developing products, unexpected regulatory actions, delays or requests, the failure of future clinical trials, inability to successfully develop our product candidates or receive necessary regulatory approvals, inability to make product candidates commercially successful, changes in anticipated expenses, and other risks and challenges detailed in our filings
'/>"/>

SOURCE Insmed Incorporated
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Insmed Incorporated Provides Corporate Update
2. Insmed Secures $20 Million Loan Agreement With Hercules Technology Growth Capital
3. Insmed Announces Financial Results For Second Quarter And Six-months Ended June 30, 2012
4. Insmed to Present at Stifel Nicolaus 2012 Healthcare Conference
5. Insmed Appoints 15-Year Life Sciences Industry Veteran Andrew Drechsler as Chief Financial Officer
6. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
7. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
8. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
9. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
10. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
11. Masimo to Present at 23rd Annual Piper Jaffray Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... Bed bug cases tend to increase during summer. ... higher risk of becoming the pests' next victim throughout the ... In the guide, the company enumerated the steps of ... traveling. , According to My Cleaning Products, there are ... infestation during summer: the warm weather and the rise in ...
(Date:5/24/2013)... 2013 Senomyx , Inc. (NASDAQ: ... technologies to discover, develop, and commercialize novel flavor ingredients, ... Ph.D., the Company,s Vice President, Biology and ... Corporate Communications, will present an overview of Senomyx,s technology ... Eastern Time (7:25 a.m. Pacific Time) during the Citi ...
(Date:5/24/2013)... Canada (PRWEB) May 24, 2013 Many ... barriers, and uptake or efflux transporters at the blood-tissue ... be related to unbound fractions in the tissue rather ... of these disposition challenges is required to guide lead ... to identify any species-dependent variables that may impact the ...
(Date:5/24/2013)... 24, 2013 Vestiage, Inc. (stock ... focused on science-based research and development, sales and ... and nutraceuticals, announced today that it is awarding ... the sale of Reluma Skin Illuminating Facial Care. ... application by sending an email to info(at)vestiageinc(dot)com and ...
Breaking Biology Technology:Steps for Getting Rid of Bed Bugs without Using Chemicals and Avoiding Them While Traveling Enumerated by My Cleaning Products in Its Latest Post 2Steps for Getting Rid of Bed Bugs without Using Chemicals and Avoiding Them While Traveling Enumerated by My Cleaning Products in Its Latest Post 3SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CITI 2013 GLOBAL CONSUMER CONFERENCE 2DMPK for Targeted Tissue Delivery: Solutions for the Most Challenging Part of Outsourcing, New Life Science Webinar Hosted by Xtalks 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 3Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 4Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 5
... 12 Aton Pharma, Inc., a global,specialty pharmaceutical ... agreement with Meizler Biopharma S/A to commercialize,CUPRIMINE(R) and ... and Meizler is working to obtain regulatory approval ... essential products, and Aton is,committed to making these ...
... 12 Covance Inc. (NYSE:,CVD) today announced that it ... on Tuesday, May 13, 2008 at 10:30 am ET. ... http://www.covance.com . In order to,register and download any ... with headquarters in Princeton, New Jersey, is one of ...
... China, May 12 /Xinhua-PRNewswire-FirstCall/ -- Tianyin,Pharmaceutical, Co., Inc., ... modernized traditional Chinese medicine ("TCM") based in,Chengdu, China, ... the Brean,Murray All-Cap All-China Conference on Tuesday, May ... be held at the Waldorf Astoria, which is ...
Cached Biology Technology:Aton Pharma Announces Distribution Partnership in Brazil 2Tianyin Pharmaceutical to Present at the Brean Murray All-Cap All-China Conference in New York City on May 20, 2008 at 10:15 a.m. EDT 2
(Date:5/22/2013)... improve durability in fuel cell powered buses, including ... links between electrode degradation processes and bus membrane ... of electrode degradation stressors in the operating cycle ... The findings of the study, led by SFU ... a long-term study at Burnaby-based Ballard Power Systems ...
(Date:5/22/2013)... must join together in a major new effort to ... in providing Earth,s people with clean water that looms ... a comment article in the current edition of ... the American Chemical Society (ACS), the world,s largest scientific ... Ph.D., and Jerald L. Schnoor, Ph.D., explain that shortages ...
(Date:5/22/2013)... new, streamlined approach to genetic engineering drastically reduces ... genes into bacteria, the workhorses of biotechnology, scientists ... Synthetic Biology , the method paves the way ... drug development, environmental cleanup and other activities. , ... integrating, a piece of the genetic material DNA ...
Breaking Biology News(10 mins):Tests lead to doubling of fuel cell life 2
... concluded that increasingly frequent and severe drought, dropping water ... ecosystems into "catastrophic regime change," from which many species ... the journal Freshwater Biology , raise concerns that ... and land management may permanently affect which species can ...
... ARLINGTON, Va.R&D Magazine honored Office of Naval Research ... "R&D 100" award on Oct. 13 for the development ... The special high-tech surface technology, HybridSil Fire/Blast, acts ... type of surface, making it blast-, ballistic- and fire-resistant. ...
... - In a nationwide study of more than 17,000 dogs ... have shown that including at least some dry food in ... and dogs compared with home-prepared alternatives. This research was conducted ... Nutrition - the fundamental science centre supporting Mars Petcare brands ...
Cached Biology News:Severe drought, other changes can cause permanent ecosystem disruption 2Severe drought, other changes can cause permanent ecosystem disruption 3Spray-on protective coating wins 'R&D 100' Award 2
... The biolistic PDS-1000 He system uses ... to accelerate micron-size nucleic acid-coated gold ... to transfect cells, tissues, or organelles ... cell surface. The system includes helium ...
Sf21 Insect Cells (Frozen) in Max-XP Medium...
... thermal cycler system is used for conventional ... includes the MyCycler personal thermal cycler, which ... with 0.2 ml tubes or plates, programmable ... algorithm and block modes of temperature control. ...
... VersArray ChipWriter Pro system with colony-picking capabilities, ... to array DNA, proteins, oligonucleotides, carbohydrates, lipids, ... substrates for microarray applications. This system can ... small as 300 micrometers in diameter and ...
Biology Products: